Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.22
0.00 (0.00%)
USD |
NASDAQ |
Oct 30, 16:00
4.23
+0.01
(+0.24%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Cash from Operations (Quarterly) : -29.63M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.63M |
| March 31, 2026 | -25.57M |
| December 31, 2025 | -15.92M |
| September 30, 2025 | -15.55M |
| June 30, 2025 | -16.60M |
| March 31, 2025 | -16.42M |
| December 31, 2024 | -10.94M |
| September 30, 2024 | -13.94M |
| June 30, 2024 | -8.943M |
| March 31, 2024 | -7.967M |
| December 31, 2023 | -6.009M |
| September 30, 2023 | -7.176M |
| June 30, 2023 | -7.800M |
| March 31, 2023 | -15.12M |
| December 31, 2022 | -7.455M |
| September 30, 2022 | -7.245M |
| June 30, 2022 | -12.23M |
| March 31, 2022 | -10.62M |
| December 31, 2021 | -9.703M |
| September 30, 2021 | 0.857M |
| June 30, 2021 | -17.53M |
| March 31, 2021 | -21.81M |
| December 31, 2020 | -18.22M |
| September 30, 2020 | -27.25M |
| June 30, 2020 | -26.61M |
| Date | Value |
|---|---|
| March 31, 2020 | -27.60M |
| December 31, 2019 | -22.56M |
| September 30, 2019 | -17.09M |
| June 30, 2019 | -16.39M |
| March 31, 2019 | 10.32M |
| December 31, 2018 | -14.06M |
| September 30, 2018 | -8.847M |
| June 30, 2018 | -5.557M |
| March 31, 2018 | -1.599M |
| December 31, 2017 | -9.114M |
| September 30, 2017 | -6.332M |
| June 30, 2017 | -5.715M |
| March 31, 2017 | -6.636M |
| December 31, 2016 | -5.479M |
| September 30, 2016 | -3.051M |
| June 30, 2016 | -2.527M |
| March 31, 2016 | -2.515M |
| December 31, 2015 | -0.881M |
| September 30, 2015 | -2.483M |
| June 30, 2015 | 0.0195M |
| March 31, 2015 | -1.280M |
| December 31, 2014 | -1.321M |
| September 30, 2014 | -0.5646M |
| June 30, 2014 | |
| March 31, 2014 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -2.213M |
| Tonix Pharmaceuticals Holding Corp. | -41.87M |
| Karyopharm Therapeutics, Inc. | -24.93M |
| Minerva Neurosciences, Inc. | -13.34M |
| Ocugen, Inc. | -12.20M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 18.26M |
| Cash from Financing (Quarterly) | 9.075M |
| Free Cash Flow | -86.69M |
| Free Cash Flow Per Share (Quarterly) | -1.527 |
| Free Cash Flow to Equity (Quarterly) | -32.69M |
| Free Cash Flow to Firm (Quarterly) | -29.63M |
| Free Cash Flow Yield | -122.8% |